Cyclerion Stock Soars 295% to $5.40 After $380M Korsana Merger Deal—What’s Driving the Surge?
Cyclerion Therapeutics stunned the market after its stock surged 295% to $5.40, driven by a headline-grabbing merger agreement with Korsana Biosciences and a massive $380 million private financing round. The…







